The National Foundation for Cancer Research (NFCR) is eager to support innovative oncology technology companies' efforts to enhance their resources so as to be able to more quickly and effectively bring better diagnostics, preventive tools and treatments to patients. Our affiliation with the 2019 China BioMed Innovation and Investment Conference (CBIIC) and organization of its International Innovative Oncology Companies Roadshow Showcase (International Showcase) has been strategically guided by this rational.
Among the largest annual life sciences industry events in the world, CBIIC presents an outstanding opportunity to meet targeted investors, as well as explore strategic licensing deals.
Please click below among the pertinent three categories, and complete and submit the generated form, if you represent:
  • A U.S. or other non-Chinese oncology technology company interested in attending the 2019 CBIIC and participating as a presenter to potential investors in its International Showcase (Showcase Participant), please apply below AND email a non-confidential presentation deck to
  • A company or organization interested in sponsoring the International Showcase (Showcase Sponsor), please apply below AND email a non-confidential presentation deck to 
  • A U.S. or other non-Chinese biomedical company, investor or other type of organization or agency committed to attending the 2019 CBIIC (Conference Attendee), please click here to register >>
As authorized by the 2019 CBIIC's host, the China Pharmaceutical Innovation and Research Development Association (PhIRDA), an NFCR representative will review and reply to valid applications which fall within either of the two former categories.  
If you have questions or need more information, please email:

© Copyright 2019 National Foundation for Cancer Research. All Rights Reserved.